These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 9685885)
1. Application of asymmetric TPX membranes to transdermal delivery of nitroglycerin. Wang DM; Lin FC; Chen LY; Lai JY J Control Release; 1998 Jan; 50(1-3):187-95. PubMed ID: 9685885 [TBL] [Abstract][Full Text] [Related]
2. Effects of intermittent transdermal nitroglycerin on occurrence of ischemia after patch removal: results of the second transdermal intermittent dosing evaluation study (TIDES-II). Pepine CJ; Lopez LM; Bell DM; Handberg-Thurmond EM; Marks RG; McGorray S J Am Coll Cardiol; 1997 Oct; 30(4):955-61. PubMed ID: 9316524 [TBL] [Abstract][Full Text] [Related]
3. Transdermal delivery of triprolidine using TPX polymer membrane. Shin SC; Kim J; Yoon MK; Oh IJ; Choi JS Int J Pharm; 2002 Mar; 235(1-2):141-7. PubMed ID: 11879749 [TBL] [Abstract][Full Text] [Related]
4. Application of TPX polymer membranes for the controlled release of triprolidine. Shin SC; Yoon MK Int J Pharm; 2002 Jan; 232(1-2):131-7. PubMed ID: 11790496 [TBL] [Abstract][Full Text] [Related]
5. Variational analysis of the transdermal delivery rate from two prototypical ethanol-water nitroglycerin TTS devices and Transderm-Nitro 10 in the normal population. Kochak GM; Berner B; Leal M; Sambol NC J Pharmacokinet Biopharm; 1992 Oct; 20(5):443-59. PubMed ID: 1287196 [TBL] [Abstract][Full Text] [Related]
6. A comparative evaluation of two transdermal nitroglycerin delivery systems: Nitro-Dur versus Transderm-Nitro. The Collaborative Investigation Group. Clin Ther; 1991; 13(5):545-9. PubMed ID: 1799911 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of adhesive properties of transdermal therapeutic systems containing nitroglycerin. Minghetti P; Casiraghi A; Cilurzo F; Montanari L Boll Chim Farm; 2001; 140(2):63-7. PubMed ID: 11417388 [TBL] [Abstract][Full Text] [Related]
8. Direct vasodilation by transdermal administration of nitroglycerin: preliminary, randomized, placebo-controlled trial of nitroglycerin skin spray for premedication before artery puncture. Tanitame K; Tani C; Nakamura Y; Yamasaki W; Ishikawa M; Kakizawa H; Date S; Awai K Jpn J Radiol; 2012 May; 30(4):370-5. PubMed ID: 22302296 [TBL] [Abstract][Full Text] [Related]
9. Application of a Stable Isotope Technique for the Bioequivalency Study of Two Transdermal Nitroglycerin Systems. Sun JX; Piraino AJ; Morgan JM; Joshi JC; Chan K; John VA; Good WR Am J Ther; 1994 Jun; 1(1):15-21. PubMed ID: 11835062 [TBL] [Abstract][Full Text] [Related]
10. Preventive effects of angiotensin-converting enzyme inhibitors on nitrate tolerance during continuous transdermal application of nitroglycerin in patients with chronic heart failure. Watanabe H; Kakihana M; Ohtsuka S; Sugishita Y Jpn Circ J; 1998 May; 62(5):353-8. PubMed ID: 9626903 [TBL] [Abstract][Full Text] [Related]
11. Studies on the response of nitroglycerin oral spray compared with sublingual tablets for angina pectoris patients with dry mouth. A multicenter trial. Sato H; Koretsune Y; Taniguchi T; Fukui S; Shimazu T; Sugii M; Matsuyama T; Karita M; Hori M Arzneimittelforschung; 1997 Feb; 47(2):128-31. PubMed ID: 9079231 [TBL] [Abstract][Full Text] [Related]
12. Transdermal nitroglycerin systems: methods for comparison. Harrison LI; Riedel DJ Clin Ther; 1991; 13(3):361-7. PubMed ID: 1954637 [TBL] [Abstract][Full Text] [Related]
13. Adverse dermatologic reaction to transdermal nitroglycerin. Letendre PW; Barr C; Wilkens K Drug Intell Clin Pharm; 1984 Jan; 18(1):69-70. PubMed ID: 6420136 [TBL] [Abstract][Full Text] [Related]
15. Transdermal nitroglycerin patch therapy improves left ventricular function and prevents remodeling after acute myocardial infarction: results of a multicenter prospective randomized, double-blind, placebo-controlled trial. Mahmarian JJ; Moyé LA; Chinoy DA; Sequeira RF; Habib GB; Henry WJ; Jain A; Chaitman BR; Weng CS; Morales-Ballejo H; Pratt CM Circulation; 1998 May; 97(20):2017-24. PubMed ID: 9610531 [TBL] [Abstract][Full Text] [Related]
16. Responsiveness of peripheral veins to transdermal and sublingual nitroglycerin in healthy male volunteers. Hiremath AN; Hoffman BB; Blaschke TF J Cardiovasc Pharmacol; 1989 Oct; 14(4):534-41. PubMed ID: 2478766 [TBL] [Abstract][Full Text] [Related]
17. Endothelial modulation and tolerance development in the vasorelaxant responses to nitrate of rabbit aorta. Nakae I; Matsumoto T; Omura T; Takashima H; Ohira N; Tarutani Y; Yasuda Y; Matsuo S; Koh T; Nakaura Y; Kinoshita M; Horie M Life Sci; 2003 Oct; 73(24):3083-94. PubMed ID: 14550849 [TBL] [Abstract][Full Text] [Related]
18. Comparison of adhesive properties of two transdermal nitroglycerin controlled-release systems. Chinoy DA; Breaux PC; Ibrahim F Clin Ther; 1985; 8(1):30-4. PubMed ID: 3938681 [TBL] [Abstract][Full Text] [Related]
19. Effects of a transdermal patch system containing nitroglycerin on exercise tolerance in patients with angina pectoris. Double-blind, placebo controlled, comparison with slow-release nifedipine and verapamil. Gibelli G; Negrini M; Mazzocchi F; Prina L; Pollavini P; De Ponti C G Ital Cardiol; 1986 Nov; 16(11):904-8. PubMed ID: 3104124 [TBL] [Abstract][Full Text] [Related]
20. Transdermal kinetics and nitrate tolerance. Measurements of vasodilation by photoplethysmography. Klemsdal TO Scand Cardiovasc J; 1997; 31(6):368. PubMed ID: 9455788 [No Abstract] [Full Text] [Related] [Next] [New Search]